377
Views
0
CrossRef citations to date
0
Altmetric
Obstetrics

The correlation between blood lipids and intrahepatic cholestasis syndrome during pregnancy

, , , , , , & show all
Article: 2369929 | Received 28 Dec 2023, Accepted 13 Jun 2024, Published online: 04 Jul 2024

References

  • Aniort, J., et al., 2017. Bile cast nephropathy caused by obstructive cholestasis. American Journal of Kidney Diseases, 69 (1), 1–9.
  • Betjes, M.G. and Bajema, I., 2006. The pathology of jaundice-related renal insufficiency: cholemic nephrosis revisited. Journal of Nephrology, 19 (2), 229–233.
  • Bosoi, C.R., et al., 2017. The bile duct ligated rat: a relevant model to study muscle mass loss in cirrhosis. Metabolic Brain Disease, 32 (2), 513–518.
  • Chen, D. and Qiu, P., 2013. A study on the value of lipid metabolism in hypothyroidism during pregnancy. Chinese Journal of Eugenics and Genetics, 21 (2), 79.
  • Cossu, E., et al., 2018. Presence of diabetes-specific autoimmunity in women with gestational diabetes mellitus (GDM) predicts impaired glucose regulation at follow-up. Journal of Endocrinological Investigation, 41 (9), 1061–1068.
  • Egerman, R.S. and Riely, C.A., 2004. Predicting fetal outcome in intrahepatic cholestasis of pregnancy: is the bile acid level sufficient? Hepatology, 40 (2), 287–288.
  • Erlinger, S., 2014. Bile acids in cholestasis: bad for the liver, not so good for the kidney. Clinics and Research in Hepatology and Gastroenterology, 38 (4), 392–394.
  • Fickert, P., et al., 2013. Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice. Hepatology, 58 (6), 2056–2069.
  • Gao, X. and Zhu, T., 2016. The relationship between serum lipid levels and pregnancy outcomes in pregnant women with diabetes in early and late pregnancy. Anhui Medicine, 20 (11), 2093–2095.
  • Guo, X., 2017. A study on the relationship between blood lipid levels and pregnancy outcomes in pregnant women. Hangzhou city: Zhejiang University.
  • Hao, H., Liu, Z., and Yang, S., 2016. Changes in blood lipid levels and clinical significance in patients with intrahepatic cholestasis of pregnancy Chinese. Journal of Clinical Obstetrics and Gynecology, 17 (4), 359–361.
  • Hofmann, A.F. and Hagey, L.R., 2008. Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cellular and Molecular Life Sciences, 65 (16), 2461–2483.
  • Holland, R.L., 1987. Recurrent intrahepatic cholestasis of pregnancy. South Dakota Journal of Medicine, 40 (4), 9–12. Apr
  • Holt, S., et al., 1999. Acute cholestasis-induced renal failure: effects of antioxidants and ligands for the thromboxane A2 receptor. Kidney International, 55 (1), 271–277.
  • Kamisako, T. and Adachi, Y., 1995. Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis. American Journal of Gastroenterology, 90 (7), 1187–1188.
  • Krones, E., et al., 2017. NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice. Journal of Hepatology, 67 (1), 110–119.
  • Kurihara, T., et al., 1993. Experimental use of pravastatin in patients with primary biliary cirrhosis associated with hypercholesterolemia. Clinical Therapeutics, 15 (5), 890–898.
  • Lammert, F., et al., 2000. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. Journal of Hepatology, 33 (6), 1012–1021.
  • Li, C. and Li, Z., 2019. The effect of individualized diet guidance combined with oral hypoglycemic drugs on glucose and lipid metabolism in pregnant women with diabetes and perinatal prognosis. Chinese Journal of Clinical Obstetrics and Gynecology, 20 (3), 243–244.
  • Li, H., 2019. Analysis of serum bile acid profile and pregnancy outcomes in intrahepatic cholestasis of pregnancy. Chongqing city: Chongqing Medical University.
  • Li, T. and Chiang, J.Y.L., 2017. Bile acid-induced liver injury in cholestasis. Springer International Publishing, 143–172.
  • Liu, H., Ao, D., and Wu, Y., 2009. Exploration of the relationship between serum total bile acids and blood lipids. Hainan Medicine, 20 (10), 125.
  • Liu, K., 2016. Clinical analysis of 456 cases of intrahepatic cholestasis of pregnancy and hypercholeacidemia of pregnancy. Chongqing city: Chongqing Medical University.
  • Lu, Y., et al., 2021. Establishment of trimester-specific reference intervals of serum lipids and the associations with pregnancy complications and adverse perinatal outcomes: a population-based prospective study. Annals of Medicine, 53 (1), 1632–1641.
  • Majsterek, M., et al., 2022. Bile acids in intrahepatic cholestasis of pregnancy. Diagnostics, 12 (11), 2746.
  • Martínez-Cecilia, D., et al., 2016. Oxidative stress influence on renal dysfunction in patients with obstructive jaundice: a case and control prospective study. Redox Biology, 8, 160–164.
  • McKenzie-Sampson, S., et al., 2018. Gestational diabetes and risk of cardiovascular disease up to 25 years after pregnancy: a retrospective cohort study. Acta Diabetologica, 55 (4), 315–322.
  • Monrose, E., et al., 2021. Burden of future liver abnormalities in patients with intrahepatic cholestasis of pregnancy. American Journal of Gastroenterology, 116 (3), 568–575.
  • O’Brien, A., et al., 2016. Bile duct-ligated mice exhibit multiple phenotypic similarities to acute decompensation patients despite histological differences. Liver International, 36 (6), 837–846.
  • Ommati, M.M., et al., 2019. Cholestasis-associated reproductive toxicity in male and female rats: the fundamental role of mitochondrial impairment and oxidative stress. Toxicology Letters, 316, 60–72.
  • Ommati, M.M., et al., 2020. Betaine alleviates cholestasis-associated renal injury by mitigating oxidative stress and enhancing mitochondrial function. Biologia, 76 (1), 351–365.
  • Ommati, M.M., et al., 2021a. Pentoxifylline mitigates cholestasis-related cholemic nephropathy. Clinical and Experimental Hepatology, 7 (4), 377–389.
  • Ommati, M.M., et al., 2021b. Mitigation of cholestasis-associated hepatic and renal injury by edaravone treatment: evaluation of its effects on oxidative stress and mitochondrial function. Liver Research, 5 (3), 181–193.
  • Ommati, M.M., et al., 2021c. Metformin alleviates cholestasis-associated nephropathy through regulating oxidative stress and mitochondrial function. Liver Research, 5 (3), 171–180.
  • Ommati, M.M., et al., 2023a. Cholestasis-associated pulmonary inflammation, oxidative stress, and tissue fibrosis: the protective role of the biogenic amine agmatine. Pharmacology, 108 (4), 379–393.
  • Ommati, M.M., et al., 2023b. Pulmonary inflammation, oxidative stress, and fibrosis in a mouse model of cholestasis: the potential protective properties of the dipeptide carnosine. Naunyn-Schmiedeberg’s Archives of Pharmacology, 396 (6), 1129–1142.
  • Panaitescu, A.M., et al., 2021. Pregnancy complications can foreshadow future disease-long-term outcomes of a complicated pregnancy. Medicina, 57 (12), 1320.
  • Perez, M.J. and Briz, O., 2009. Bile-acid-induced cell injury and protection. World Journal of Gastroenterology, 15 (14), 1677–1689.
  • Piechota, J. and Jelski, W., 2020. Intrahepatic cholestasis in pregnancy: review of the literature. Journal of Clinical Medicine, 9 (5), 1361.
  • Reyes, H. and Sjövall, J., 2000. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Annals of Medicine, 32 (2), 94–106.
  • Sheng, Y., Guo, J., and Chen, Z., 2017. Exploration of the relationship between late pregnancy blood lipid levels and pregnancy complications. Journal of Changzhi Medical College, 31 (3), 207–209.
  • Stamp, D., and Jenkins, G., 2008. An overview of bile-acid synthesis, chemistry and function. In: Jenkins GJ, Hardie L, editors. Bile Acids: Toxicology and Bioactivity: The Royal Society of Chemistry. p. 1–13.
  • Stojakovic, T., et al., 2007. Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid. Hepatology, 46 (3), 776–784.
  • Sulaiman, W.N.W., et al., 2016. Does high-density lipoprotein protect vascular function in healthy pregnancy? Clinical Science (London, England: 1979), 130 (7), 491–497.
  • Walker, I.A., Nelson-Piercy, C., and Williamson, C., 2002. Role of bile acid measurement in pregnancy. Annals of Clinical Biochemistry, 39 (Pt 2), 105–113.
  • Wen, C. and Liu, M., 2015. Blood lipid changes and clinical significance in intrahepatic cholestasis of pregnancy. Modern Medicine and Health, 31 (11), 1617–1618.
  • Wensink, M.J., 2016. The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age: various objections. American Journal of Obstetrics and Gynecology, 215 (6), 807–808.
  • Williamson, C. and Geenes, V., 2014. Intrahepatic cholestasis of pregnancy. Obstetrics and Gynecology, 124 (1), 120–133.
  • Zeng, G., Zou, W., and Liu, C., 2021. Study on the characteristics of lipidmetabolism in pre eclampsia, gestational diabetes and intrahepaticcholestasis of pregnancy. Modern Pharmaceutical Applications in China, 15 (8), 78–80.
  • Zhang, J., 2018. The effect of total bile acid levels on pregnancy outcomes and perinatal outcomes in pregnant women with intrahepatic cholestasis of pregnancy. Maternal and Child Health Care in China, 33 (13), 2939–2941.
  • Zheng, Y. and Zhai, G., 2013. Exploration of pregnancy and abnormal lipid metabolism. Medical Review, 19 (21), 3874–3876.
  • Zhong, H., 2004. The clinical significance of elevated serum total bile acids in late pregnancy. Anhui Medicine, 2004 (4), 270.
  • Zhou, J., 2019. Analysis of the relationship between abnormal blood lipids in the third trimester of pregnancy and maternal and fetal outcomes in patients with gestational diabetes. Modern Practical Medicine, 31 (1), 75–77.
  • Zhou, S., Li, Y., and Lin, J., 2020. The level of blood sugar and blood lipid in pregnant women with diabetes and their influence on pregnancy outcome. Chinese Medical Innovation, 17 (22), 48–51.